Endogenous cardiotonic steroids: Physiology, pharmacology, and novel therapeutic targets

Pharmacological Reviews

Volumn 61, Issue 1, 2009, Pages 9-38

  Bagrov, Alexei Y ^a   Shapiro, Joseph I ^b   Fedorova, Olga V ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BUFADIENOLIDE; CARDENOLIDE; CARDIOTONIC AGENT; CYCLIC GMP DEPENDENT PROTEIN KINASE; DIGITALIS LIKE FACTOR; MARINOBUFAGENIN; NATRIURETIC FACTOR; OUABAIN; PROTEIN KINASE C; STEROID;

ALCOHOLISM; APOPTOSIS; ARTERIAL PRESSURE; BEHAVIORAL STRESS; CARBOHYDRATE METABOLISM; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL GROWTH; CENTRAL NERVOUS SYSTEM; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; EXERCISE; FIBROSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HORMONAL REGULATION; HUMAN; HYPERTENSION; IMMUNOMODULATION; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; MALIGNANT NEOPLASTIC DISEASE; MOOD DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROME; SODIUM INTAKE; SODIUM METABOLISM; SODIUM TRANSPORT; STEROIDOGENESIS;

ANIMALS; BLOOD PRESSURE; BUFANOLIDES; CARDIAC GLYCOSIDES; CARDIOTONIC AGENTS; DIABETES MELLITUS; ENZYME INHIBITORS; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; OUABAIN; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 63849168850     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.108.000711     Document Type: Review

References (403)

1. Adair CD, Buckalew V, Taylor K, Ernest JM, Frye AH, Evans C, and Veille JC (1996) Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin. Am J Nephrol 16:529-531.
2. Adair CD, Luper A, Rose JC, Russell G, Veille JC, and Buckalew VM (2009) The hemodynamic effects of intravenous digoxin-binding Fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial. J Perinatol doi: 10.1038/jp.2008.224
3. Adams RJ, Schwartz A, Grupp G, Grupp I, Lee SW, Wallick ET, Powell T, Twist VW, and Gathiram P (1982) High-affinity ouabain binding site and low-dose positive inotropic effect in rat myocardium. Nature 296:167-169.
4. Agnoletti G, Rodella A, Ferrari R, and Harris (1987) Release of atrial natriuretic peptide-like immunoreactive material during stretching of the rat atrium in vitro. J Mol Cell Cardiol 19:217-220.
5. Akera T and Brody TM (1977) The role of Na,K-ATPase in the inotropic action of digitalis. Pharmacol Rev 29:187-220.
6. i-independent signaling in C7-MDCK cells. J Biol Chem 280:832-839.
7. +-ATPase internalization and de novo gene expression. Pflugers Arch 455:711-719.
8. Akimova OA, Poirier M, Kotelevtsev SV, Hamet P, and Orlov SN (2008b) The death of ouabain-treated renal epithelial cells: evidence against anoikis occurrence. Apoptosis 13:670-680.
9. Albers RW (1967) Biochemical aspects of active transport. Annu Rev Biochem 36:727-756.
10. Amin MS, Wang HW, Reza E, Whitman SC, Tuana BS, and Leenen FH (2005) Distribution of epithelial sodium channels and mineralocorticoid receptors in cardiovascular regulatory centers in rat brain. Am J Physiol Regul Integr Comp Physiol 289:R1787-R1797.
11. Amler E, Cester N, Salvolini E, Staffolani R, Burkhard M, Mazzanti L, Kotyk A, and Romanini C (1994) Human hypertensive placenta contains an increased amount of Na,K-ATPase with higher affinity for cardiac glycosides. Cell Biol Int 18:723-727.
12. Anderson DE, Bagrov AY, and Austin JL (1995) Inhibited breathing decreases renal sodium excretion. Psychosom Med 57:373-380.
13. Anderson DE, Fedorova OV, Morrell CH, Kashkin VA, Bagrov AY, and Lakatta EG (2008) Endogenous sodium pump inhibitors are linked to age-associated increases in salt sensitivity of blood pressure in normotensives. Am J Physiol Regul Integr Physiol 294:R1248-R1254.
14. Antolovic R, Bauer N, Mohadjerani M, Kost H, Neu H, Kirch U, Grunbaum EG, and Schoner W(2000) Endogenous ouabain and its binding globulin: effects of physical exercise and study on the globulin's tissue distribution. Hypertens Res 23 (Suppl):S93-S98.
15. Antolovic R, Kost H, Mohadjerani M, Linder D, Linder M, and Schoner W (1998) A specific binding protein for cardiac glycosides exists in bovine serum. J Biol Chem 273:16259-16264.
16. Aperia A, Holtback U, Syren ML, Svensson LB, Fryckstedt J, and Greengard P (1994) Activation/deactivation of renal Na,K-ATPase: a final common pathway for regulation of natriuresis. FASEB J 8:436 -469.
17. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM, and American Heart Association (2006) Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47:296 -308.
18. Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG, and Bagrov AY (2006) Endogenous Na/K-ATPase inhibitors in patients with preeclampsia. Cell Mol Biol 52:19-23.
19. Bagrov AY, Bagrov YY, Fedorova OV, Kashkin VA, Patkina NA, and Zvartau EE (2002) Endogenous digitalis-like ligands of the sodium pump: possible involvement in mood control and ethanol addiction. Eur Neuropsychopharmacol 12:1-12.
20. Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, and Droy-Lefaix MT (2000) Cicletanine reverses vasoconstriction induced by a putative endogenous Na/K ATPase ligand, marinobufagenin, via protein kinase C dependent mechanism. J Hypertens 18:209 -215.
21. Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, and Shpen VM (1996a) Endogenous marinobufagenin-like immunoreactive substance: a possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity. Am J Hypertens 9:982-990.
22. +-pump in human mesenteric arteries. J Hypertens 16:1953-1958.
23. Bagrov AY, Fedorova OV, Austin JL, Dmitrieva RI, and Anderson DE (1995a) Endogenous marinobufagenin-like immunoreactive factor and Na,K-ATPase inhibition during voluntary hypoventilation. Hypertension 26:781-788.
24. Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, and Anderson DE (1996b) Plasma marinobufagenin-like and ouabain-like immunoreactivity during acute saline volume expansion in anesthetized dogs. Cardiovasc Res 206:296-305.
25. +-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31:1097-1103.
26. Bagrov AY, Fedorova OV, Maslova MN, Roukoyatkina NI, Stolba P, and Zhabko EP (1989) Antiarrhythmic effect of antibodies to digoxin in acute myocardial ischemia in rats. Eur J Pharmacol 162:195-196.
27. Bagrov AY, Fedorova OV, Maslova MN, Roukoyatkina NI, Ukhanova MV, and Zhabko EP (1991) Endogenous plasma Na,K-ATPase inhibitory activity and digoxin-like immunoreactivity after acute myocardial infarction. Cardiovasc Res 25:371-377.
28. Bagrov AY, Fedorova OV, Roukoyatkina NI, Ukhanova MV, and Zhabko EP (1993a) Digitalis-like and vasoconstrictor properties ofendogenous digoxin-like factor from Bufo marinus toad. Eur J Pharmacol 234:165-172.
29. Bagrov AY, Fedorova OV, Roukoyatkina NI, and Zhabko EP (1993b) Effect of antidigoxin antibody on myocardial Na,K-pump activity and of endogenous digoxin-like factor in acute myocardial ischemia in rats. Cardiovasc Res 27:1045-1050.
30. Bagrov AY, Kuznetsova EA, Fedorova OV (1994) Endogenous digoxin-like factor in acute myocardial infarction. J Intern Med 235:63-67.
31. Bagrov AY, Roukoyatkina NI, Dmitrieva RI, Pinaev AG, and Fedorova OV (1995b) Effects of two endogenous digitalis-like factors, ouabain and marinobufagenin in isolated rat aorta. Eur J Pharmacol 274:151-158.
32. Bagrov YY, Dmitrieva NI, and Manusova NB (1996c) Competition of ethanol with endogenous digoxin-like factor as a possible mechanism of addiction. Dokl Akad Nauk (Proc Russ Acad Sci) 348:268-269 (in Russian). Bagrov YY, Dmitrieva NI, Manusova NB, Zvartau EE, Patkina NA and Bagrov AY (1999) Possible role ofendogenous digitalis-like factor in the voluntaryselection of alcohol by rats. Life Sci 64:PL219-PL225.
33. Bagrov YY, Manusova NB, Egorova IA, Fedorova OV, and Bagrov AY (2005) Endogenous digitalis-like substances and Na/K-ATPase inhibition in diabetes mellitus. Front Biosci 10:2257-2262.
34. Bagrov YY, Manusova NB, Frolova EV, Egorova IA, Kashkin VA, Tapilskaya NI, Fedorova OV, and Bagrov AY (2007) Endogenous sodium pump inhibitors, diabetes mellitus and preeclampsia: preliminary observations and a hypothesis. Pathophysiology 14:147-151.
35. Balzan S, Neglia D, Ghione S, D'Urso G, Baldacchino MC, Montali U, and L'Abbate A (2001) Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction. Eur J Heart Fail 3:165-171.
36. Balzan S, Nicolini G, Iervasi A, Di Cecco P, and Fommei E (2005) Endogenous ouabain and acute salt loading in low-renin hypertension. Am J Hypertens 18:906-909.
37. Bauer N, Muller-Ehmsen J, Kramer U, Hambarchian N, Zobel C, Schwinger RH, Neu H, Kirch U, Griinbaum EG, and Schoner W (2005) Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of β-blockade and angiotensin-converting enzyme inhibition. Hypertension 45:1024-1028.
38. Bergdahl B, Dahlstrom G, Molin L, and Bertler A (1979) Inter and intra laboratory variation of digoxin radioimmunoassay in Sweden. Acta Pharmacol Toxicol (Copenh) 45:66-72.
39. Bergdahl B and Molin L (1981) Precision ofdigoxin radioimmunoassays and matrix effects: four kits compared. Clin Biochem 14:67-71.
40. Bernini G, Paci A, Sgrò M, Moretti A, and Salvetti A (1998) Endogenous digitalis-like factor and ouabain immunoreactivity in adrenalectomized patients and normal subjects after acute and prolonged salt loading. Am J Hypertens 11:1-7.
41. +-ATPase inhibits the activity of the enzyme. Proc Natl Acad Sci U S A 88:11359-11362.
42. Bertorello AM and Katz AI (1993) Short-term regulation of renal Na-K-ATPase activity: physiological relevance and cellular mechanisms. Am J Physiol 265:F743-F755.
43. Bianchi G, Tripodi G, Casari G, Salardi S, Barber BR, Garcia R, Leoni P, Torielli L, Cusi D, Ferrandi M, et al. (1994) Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci U S A 26:3999 -4003.
44. Blanco G, Koster JC, Sanchez G, and Mercer RW (1995) Kinetic properties of the αcolon2ampersandbeta;1 and αcolon2ampersandbeta;2 isozymes of the Na,K-ATPase. Biochemistry 34:319-325.
45. Blanco G, Melton RJ, Sánchez G, and Mercer RW (1999) Functional characterization of a testes-specific a-subunit isoform of the sodium/potassium adenosinetriphosphatase. Biochemistry 38:13661-13669.
46. Blanco G and Mercer RW (1998) Isozymes of the Na/K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 275:F633-F650.
47. Blanco G, Sanchez G, and Mercer RW (1998) Differential regulation of Na,K-ATPase isozymes by protein kinases and arachidonic acid. Arch Biochem Biophys 359:139 -150.
48. 2+ stores and cell responsiveness. Am J Physiol 264:C1367-1387.
49. +pump inhibition after saline infusion in essentially hypertensive subjects: effects of canrenone administration. Int J Cardiol 25 (Suppl 1):S47-S52.
50. +-ATPase subunit isoforms at mRNA and protein levels in rat myocardium. J Mol Cell Cardiol 25:591-600.
51. Bourgoignie JJ, Weisser F, Rolf D, Klahr S, and Bricker NS (1970) Demonstration of a low-molecular-weight natriuretic factor in uremic serum. Trans Assoc Am Physicians 83:277-287. Braunwald E and Klocke FJ (1965) Digitalis. Annu Rev Med 16:371-386.
52. Bricker NS, Schmidt RW, Favre H, Fine L, and Bourgoignie JJ (1975) On the biology of sodium excretion: the search for natriuretic hormone. Yale J Biol Med 48:293-303.
53. Briones AM, Xavier FE, Arribas SM, Gonzalez MC, Rossoni LV, Alonso MJ, and Salaices M (2006) Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol 291:H193-H201.
54. Bruneau BG, Piazza LA, and de Bold AJ (1997) BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 273:H2678-H2686.
55. Buckalew VM Jr, Martinez FJ, and Green W (1970) The effect of dialysates and ultrafiltrates of plasma and saline-loaded dogs on toad bladder sodium transport. J Clin Invest 49:926 -935.
56. Burns EL, Nicholas RA, and Price EM (1996) Random mutagenesis of the sheep Na,K-ATPase a1 subunit generating the ouabain-resistant mutant L793P. J Biol Chem 271:15879-15883.
57. Butler VP Jr, Morris JF, Akizawa T, Matsukawa M, Keating P, Hardart A, and Furman I (1996) Heterogeneity and lability of endogenous digitalis-like substances in the plasma of the toad, Bufo marinus. Am J Physiol 271:R325-R332.
58. Butt AN, Semra YK, Ho CS, and Swaminathan R (1997) Effect ofhighsalt intake on plasma and tissue concentration of endogenous ouabain-like substance in the rat. Life Sci 61:2367-2373.
59. +ATPase receptor complex. Am J Physiol Cell Physiol 294:C555-C563.
60. Carroll JS, Seely EW, Tao QF, and Graves SW (2001) Digitalis-like factor response to hyperinsulinemia accompanying a euglycemic hyperinsulinemic clamp or oral glucose tolerance test. Life Sci 69:829 -837.
61. Charlemagne D, Orlowski J, Oliviero P, Rannou F, Sainte Beuve C, Swynghedauw B, and Lane LK (1994) Alteration of Na,K-ATPase subunit mRNAand protein levels in hypertrophied rat heart. J Biol Chem 269:1541-1547.
62. Chen C and Osuch MV (1969) Biosynthesis of bufadienolides-3-β- hydroxycholanates as precursors in Bufo marinus bufadienolides synthesis. Biochem Pharmacol 18:1797-1802.
63. Chen KK and Kovarikova A (1967) Pharmacology and toxicology of toad venom. J Pharm Sci 56:1535-1541.
64. Chen S, Yuan C, Clough D, Schooley J, Haddy FJ, and Pamnani MB (1993) Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats. Am J Hypertens 6:397-406.
65. CheungWJ, KentMA, El-ShahatE, WangH, Tan J, White R, and Leenen FH(2006) Central and peripheral renin-angiotensin systems in ouabain-induced hypertension. Am J Physiol Heart Circ Physiol 291:H624-H630.
66. +-ATPase is initiated by phosphorylation of Ser-18 in the rat a subunit and is responsible for the decreased activity in epithelial cells. J Biol Chem 274:1920-1927.
67. Choi SJ, Taylor MA, and Abrams R (1977) Depression, ETC and erythrocyte adenosine triphosphatase activity. Biol Psychiatry 12:75-81.
68. Clerico A, Cambi A, Del Chicca MG, Cecchini L, and Giaconi S (1988) Urinary excretion of digoxin-like immunoreactivity after physical exercise. Clin Chem 34:215.
69. Clerico A and Giampietro O (1990) Is the endogenous digitalis-like factor the link between hypertension and metabolic disorders as diabetes mellitus, obesity and acromegaly? Clin Physiol Biochem 8:153-168.
70. Cornelius F and Mahmmoud YA (2003) Direct activation of gastric H,K-ATPase by N-terminal protein kinase C phosphorylation: comparison of the acute regulation mechanisms of H,K-ATPase and Na,K-ATPase. Biophys J 84:1690 -1700.
71. Cort JH and Lichardus B (1963) The natriuretic activity of jugular vein blood during carotid occlusion. Physiol Bohemoslov 12:497-501.
72. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, and Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735-741.
73. +-ATPase isoforms by endogenous digitalis extracts from neonatal human plasma. Clin Exp Hypertens 20:669 -674.
74. Crambert G and Geering K (2003) FXYD proteins: new tissue-specific regulators of the ubiquitous Na,K-ATPase. Sci STKE 2003:RE1.
75. +-ATPase alpha subunit identifies known and previously unidentified amino acid residues that alter ouabain sensitivity-implications for ouabain binding. Eur J Biochem 248:488-495.
76. Dahl LK, Knudsen KD, and Iwai J (1969) Humoral transmission of hypertension: evidence from parabiosis. Circ Res 24 (Suppl):21-33. de Bold AJ, Borenstein HB, Veress AT, and Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89 -94.
77. Delva P, Barbieri E, Devynck M-A, Meyer P, Destro G, Capra C, Pernollet MG, Zardini P, and Lechi A (1990) Increase in plasma digitalis like activity during percutaneous transluminal angioplasty in patients with coronary stenosis. Life Sci 47:385-389.
78. de Mendonca M, Grichois ML, Pernollet MG, Wauquier I, Trouillet-Thormann B, Meyer P, Devynck MA, and Garay R (1988) Antihypertensive effect of canrenone in a model where endogenous ouabain-like factors are present. J Cardiovasc Pharmacol 11:75-83.
79. de Wardener HE and Clarkson EM (1985) Concept of natriuretic hormone. Physiol Rev 65:658-759.
80. de Wardener HE, Clarkson EM, Nutbourne DM, Schrier RW, Talner LB, Ventom MG, and Verroust PJ (1971) Evidence for a hormone other than aldosterone which controls urinary sodium excretion. Adv Nephrol Necker Hosp 1:97-111.
81. de Wardener HE, Fabian M, Jones JJ, Lee J, Schrier RW, and Verroust PJ (1968) The effect of acute extracellular fluid volume expansion and acute hemorrhage on plasma antidiuretic hormone and oxytocin levels in dogs. J Physiol 196:121P- 22P.
82. De Wardener HE and MacGregor GA (2002) Sodium and blood pressure. Curr Opin Cardiol 17:360 -367.
83. De Wardener HE, Mills IH, Clapham WF, and Hayter CJ (1961) Studies on the efferent mechanism of the sodium diuresis which follows the administration of intravenous saline in the dog. Clin Sci 21:249 -258.
84. Di Grande A, Boura AL, Read MA, Malatino LS, and Walters WA (1993) Release of a substance from the human placenta having digoxin-like immunoreactivity. Clin Exp Pharmacol Physiol 20:603-607.
85. Dmitrieva RI, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM, and Doris PA (2000) Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage. Hypertension 36:442-448.
86. Dmitrieva RI, Lalli E, and Doris PA (2005) Regulation of adrenocortical cardiotonic steroid production by dopamine and PKA signaling. Front Biosci 10:2489 -2495.
87. Doris PA, Jenkins LA, and Stocco DM (1994) Is ouabain an authentic endogenous mammalian substance derived from the adrenal? Hypertension 23:632-638.
88. Doris PA, Kilgore MW, Durham D, Alberts D, and Stocco DM (1989) An endogenous digitalis-factor derived from the adrenal gland: studies of adrenocortical tumor cells. Endocrinology 125:2580 -2586.
89. Dostanic I, Lorenz JN, Schultz Jel J, Grupp IL, Neumann JC, Wani MA, and Lingrel JB (2003) The α2 isoform of Na,K-ATPase mediates ouabain-induced cardiac inotropy in mice. J Biol Chem 278:53026 -53034.
90. Dostanic I, Paul RJ, Lorenz JN, Theriault S, Van Huysse JW, and Lingrel JB (2005) The α2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288:H477-H485.
91. Dostanic I, Schultz Jel J, Lorenz JN, and Lingrel JB (2004) The a1 isoform of Na,K-ATPase regulates cardiac contractility and functionally interacts and colocalizes with the Na/Ca exchanger in heart. J Biol Chem 279:54053-54061.
92. +ATPase and biological significance of their cardiac glycoside binding site. Am J Physiol Regul Integr Comp Physiol 290:R524-R528.
93. Dostanic-Larson I, Van Huysse JW, Lorenz JN, and Lingrel JB (2005) The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci U S A 102:15845- 15850.
94. +-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 95:1100 -1108.
95. Ehlenz K, Peter JH, Kaffarnik H, and von Wichert P (1991) Disturbances in volume regulating hormone system a key to the pathogenesis of hypertension in obstructive sleep apnea syndrome? Pneumologie 45 (Suppl 1):239 -245.
96. Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, Kim EG, Smaili S, Periyasamy SM, Hariri IM, Fedorova L, et al. (2007) Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 49:215-224.
97. el-Mallakh RS, Harrison LT, Li R, Changaris DG, and Levy RS (1995) An animal model for mania: preliminary results. Progr Neuropsychopharmacol Biol Psychiatry 19:955-962.
98. el-Mallakh RS and Wyatt RJ (1995) The Na,K-ATPase hypothesis for bipolar illness. Biol Psychiatry 37:235-244.
99. el-Masri MA, Clark BJ, Qazzaz HM, and Valdes R Jr (2002) Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors. Clin Chem 48:1720 -1730.
100. El-Okdi N, Smaili S, Raju V, Shidyak A, Gupta S, Fedorova L, Elkareh J, Periyasamy S, Shapiro AP, Kahaleh MB, et al. (2008) Effects of cardiotonic steroids on dermal collagen synthesis and wound healing. J Appl Physiol 105:30 -36.
101. Fambrough DM (1988) The sodium pump becomes a family. Trends Neurosci 11:325-328.
102. Farley RA, Heart E, Kabalin M, Putnam D, Wang K, Kasho VN, and Faller LD (1997) Site-directed mutagenesis of the sodium pump: analysis of mutations to amino acids in the proposed nucleotide binding site by stable oxygen isotope exchange. Biochemistry 36:941-951.
103. Fedorova OV, Agalakova NI, Morrell CH, Lakatta EG, and Bagrov AY (2006) ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta. Hypertension 48:1160 -1168.
104. Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, and Bagrov AY (2005a) Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl loaded Dahl-S rats. J Hypertens 23:1515-1523.
105. Fedorova OV, Anderson DE, and Bagrov AY (1998) Endogenous digitalis-like factors and Na,K-ATPase inhibition in ACTH hypertension in rats. Am J Hypertens 11:796 -802.
106. Fedorova OV, Anderson DE, Lakatta EG, and Bagrov AY (2001a) Interaction of high sodium chloride intake and psychosocial stress on endogenous ligands of the sodium pump and blood pressure in normotensive rats. Am J Physiol 281:R352-R358.
107. Fedorova OV and Bagrov AY (1997) Inhibition ofNa/K ATPase from rat aorta by two endogenous Na/K pump inhibitors, ouabain and marinobufagenin. Evidence of interaction with different alpha-subinit isoforms. Am J Hypertens 10:929 -935.
108. Fedorova OV, Doris PA, and Bagrov AY (1998) Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin Exp Hypertens 20:581-591.
109. Fedorova OV, Dorofeeva NA, Lopatin DA, Lakatta EG, and Bagrov AY (2002a) Phorbol diacetate potentiates Na/K-ATPase inhibition by a putative endogenous ligand, marinobufagenin. Hypertension 39:298 -302.
110. Fedorova OV, French AW, and Anderson DE (1996) Inhibition of erythrocyte Na,KATPase activity during anticipatory hypoventilation in micropigs. Am JHypertens 9:1126 -1131.
111. Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, and Bagrov AY (2001b) Marinobufagenin, an endogenous a-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 37:462-466.
112. Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J, Lakatta EG, and Bagrov AY (2005b) Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 23:835-842.
113. Fedorova OV, Lakatta EG, and Bagrov AY (2000) Differential effects of acute NaCl loading on endogenous ouabain-like and marinobufagenin-like ligands of the sodium pump in Dahl hypertensive rats. Circulation 102:3009 -3014.
114. Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, Tapilskaya NI, Bzhelyansky AM, Reznik VA, Nikitina ER, et al. (2008) Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition in lowers blood pressure in NaCl-sensitive hypertension. J Hypertens 26:2414 -2425.
115. Fedorova OV, Talan MI, Agalakova NI, Droy-Lefaix M-T, Lakatta EG, and Bagrov AY (2003) Reduction in myocardial PKC β-2, Na/K-ATPase sensitivity to marinobufagenin and blood pressure in response to cicletanine. Hypertension 41:505 511.
116. Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, and Bagrov AY (2002b) An endogenous ligand of α-1 sodium pump, marinobufagenin, is a novel mediator of sodium chloride dependent hypertension. Circulation 105:1122-1127.
117. Fedorova OV, Talan MI, Agalakova NI, Lakatta EG, and Bagrov AY (2004) Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension. J Hypertens 22:389 -397.
118. Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG, and Bagrov AY (2007) Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J Hypertens 25:1834-1844.
119. +-ATPase and cardiac steroids in the regulation of endocytosis. Am J Physiol Cell Physiol 293:C885-C896.
120. Ferrandi M, Barassi P, Molinari I, Torielli L, Tripodi G, Minotti E, Bianchi G, and Ferrari P (2005) Ouabain antagonists as antihypertensive agents. Curr Pharm Des 11:3301-3305.
121. Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, and Ferrari P (1993) Characteristics of a ouabain-like factor from Milan hypertensive rats. J Cardiovasc Pharmacol 22 (Suppl 2):S75-S78.
122. Ferrandi M, Molinari I, Barassi P, Minotti E, Bianchi G, and Ferrari P (2004) Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J Biol Chem 279:33306 -33314.
123. Ferrari P, Ferrandi M, Tripodi G, Torielli L, Padoani G, Minotti E, Melloni P, and Bianchi G (1999) PST 2238: a new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. J Pharmacol Exp Ther 288:1074-1083.
124. +-ATPase alterations in ouabain and adducin-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 290:R529 -R535.
125. 18 occurs in intact cells but does not result in direct inhibition of ATP hydrolysis. J Biol Chem 272:17726- 17733.
126. Feschenko MS, Wetzel RK, and Sweadner KJ (1997) Phosphorylation of Na,KATPase by protein kinases: sites, susceptibility, and consequences. Ann NY Acad Sci 834:479 -488.
127. Finotti P and Palatini P (1981) Canrenone as a partial agonist at the digitalis receptor site ofsodium-potassium-activated adenosine triphosphatase. J PharmacolExp Ther 217:784-790.
128. +ATPase. Science 208:503-505.
129. Foley TD and Linnoila M (1995) Nanomolar concentrations ofouabain block ethanol inducible Na,K-ATPase activity in brain. Eur J Pharmacol 292:287-292.
130. Foley TD and Rhoads DE (1994) Stimulation of Na,K-ATPase by ethanol: possible involvement of an isozyme-specific inhibitor of Na/K-ATPase. Brain Res 653:167-172.
131. +)-ATPase, depending upon Na and K concentrations. Alcohol 6:437-443.
132. +-ATPase from mammalian kidneys and Xenopus oocytes by cGMP dependent protein kinase results in stimulation of ATPase activity. Eur JBiochem 260:904-910.
133. Franzin CM, Yu J, Thai K, Choi J, and Marassi FM (2005) Correlation of gene and protein structures in the FXYD family proteins. J Mol Biol 354:743-750.
134. Fridman AI, Matveev SA, Agalakova NI, Fedorova OV, Lakatta EG, and Bagrov AY (2002) Marinobufagenin, an endogenous ligand of a-1 Na/K-ATPase, is a marker of congestive heart failure severity. JHypertens 20:1189-1194.
135. Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L, and Harlap S (2005) Long-term mortality after preeclampsia. Epidemiology 16:206 -215.
136. Fuse K, Satoh M, Yokota T, Ohdaira T, Muramatsu Y, Suzuki E, and Arakawa M (1999) Regulation ofventilation before and after sleep in patients with obstructive sleep apnoea. Respirology 4:125-130
137. Gabor A and Leenen FH (2009) Mechanisms in the PVN mediating local and central sodium-induced hypertension in Wistar rats. Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.90417.2008.
138. Gallery ED, Hunyor SM, and Gyory AZ (1979) Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med 192:593-602.
139. 14C]pregnenolone in the toad Bufo arenarum. Steroids 48:251-257.
140. + pump in human red blood cells. Naunyn SchmiedebergsArch Pharmacol 329:311-315.
141. Gault MH, Vasdev S, Longerich L, Johnson E, Farid N, Legal Y, Prabhakaran V, and Fine A (1988) Evidence for an adrenal contribution to plasma digitalis-like factors. Clin Physiol Biochem 6:253-261.
142. Gillis RA and Quest JA (1979) The role of the nervous system in the cardiovascular effects of digitalis. Pharmacol Rev 31:19 -97
143. Geering K (2005) Function ofFXYD proteins, regulators ofNa,K-ATPase. JBioenerg Biomembr 37:387-392.
144. Geering K (2006) FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal Physiol 290:F241-F250.
145. Gerbi A, Barbey O, Raccah D, Coste T, Jamme I, Nouvelot A, Ouafik L, Levy S, Vague P, and Maixent JM (1997) Alteration of Na,K-ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia 40:496 -505.
146. Ghoumari AM, Piochon C, Tomkiewicz C, Eychenne B, Levenes C, Dusart I, Schumacher M, and Baulieu EE (2006) Neuroprotective effect of mifepristone involves neuron depolarization. FASEB J 20:1377-1386.
147. Gilson GJ, Graves SW, Qualls CR, and Curet LB (1997) Digoxin-like immunoreactive substance and sodium-potassium-adenosine triphosphatase inhibition in normal pregnancy: a longitudinal study. Obstet Gynecol 89:743-746.
148. Glynn IM (1993) Annual Review prize lecture: 'All hands to the sodium pump J Physiol 462:1-30.
149. +-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 60:491-499.
150. Gonick HC, Ding Y, Vaziri ND, Bagrov AY, and Fedorova OV (1998) Simultaneous measurement of marinobufagenin, ouabain, and hypertension- associated protein in various disease states. Clin Exp Hypertens 20:617-627.
151. Goodlin RC (1988) Antidigoxin antibodies in eclampsia. N Engl J Med 318:518-519.
152. Göcolonõz M, Tóth M, Vakkuri O, Göcolonõz P, Smolka AJ, de Chatel R, and Szalay KS (2004) Endogenous ouabain-like factor (OLF) secretion is modulated by nicotinic mechanisms in rat adrenocortical cells. Life Sci 74:2111-2128.
153. Goto A, Ishiguro T, Yamada K, Ishii M, Yoshioka M, Eguchi C, Shimora M, and Sugimoto T (1990) Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem Biophys Res Commun 173:1093-1101.
154. Goto A, Yamada K, Ishii M, Sugimoto T, and Yoshioka M (1991a)
155. Goto A, Yamada K, Nagoshi H, Terano Y, and Omata M (1995) Stress-induced elevation of ouabainlike compound in rat plasma and adrenal. Hypertension 26:1173-1176.
156. Goto A, Yamada K, Yagi N, Hui C, and Sugimoto T (1991b) Digoxin-like immunoreactivity: is it still worth measuring? Life Sci 49:1667-1678.
157. Goto A, Yamada K, Yagi N, Yoshioka M, and Sugimoto T (1992) Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 44:377-399.
158. Gottlieb SS, Rogowski AC, Weinberg M, Krichten CM, Hamilton BP, and Hamlyn JM (1992) Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 86:420-425.
159. Grider G, el-Mallakh RS, Huff MO, Buss TJ, Miller J, and Valdes R Jr (1999) Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord 54:261-267.
160. Graves SW (1987) The possible role of digitalis-like factors in pregnancy-induced hypertension. Hypertension 10:I84-I86.
161. Graves SW, Markides KE, and Hollenberg NK (2000) Application of supercritical fluid chromatography to characterize a labile digitalis-like factor. Hypertension 36:1059-1064.
162. Graves SW, Valdes R Jr, Brown BA, Knight AB, and Craig HR (1984) Endogenous digoxin-immunoreactive substance in human pregnancies. J Clin Endocrinol Metab 58:748-751.
163. Gruber KA, Whitaker JM, and Buckalew VM Jr Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature 287:743-745, 1980.
164. Gusdon JP Jr, Buckalew VM Jr, and Hennessy JF (1984) A digoxin-like immunoreactive substance in preeclampsia. Am J Obstet Gynecol 150:83-85.
165. +-ATPase. J Biol Chem 275:27832-27837.
166. +-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem 277:18694-18702.
167. Haddy FJ (2006) Role of dietary salt in hypertension. Life Sci 79:1585-1592.
168. Haddy FJ and Overbeck HW(1976) The role of humoral agents in volume expanded hypertension. Life Sci 19:935-947.
169. Hamlyn JM (2004) Biosynthesis of endogenous cardiac glycosides by mammalian adrenocortical cells: three steps forward. Clin Chem 50:469 -470. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, and Ludens JH (1991) Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 88:6259 -6263.
170. +)ATPase associated with essential hypertension. Nature 300:650-652.
171. +-ATPase interaction with putative endogenous ouabain. Eur J Biochem 270:1916-1919.
172. Harnett JD and Parfrey PS (1994) Cardiac disease in uremia. Semin Nephrol 14:245-252.
173. Hauptman PJ and Kelly RA (1999) Digitalis. Circulation 99:1265-1270.
174. +-ATPase. Clin Exp Pharmacol Physiol 16:623-629.
175. Hesketh JE, Glen AI, and Reading HW (1977) Membrane ATPase activities in depressive illness. J Neurochem 28:1401-1402.
176. Hieber V, Siegel GJ, Fink DJ, Beaty MW, and Mata M (1991) Differential distribution of (Na,K)-ATPase a isoforms in the central nervous system. Cell Mol Neurobiol 11:253-262.
177. Hilton PJ, White RW, Lord GA, Garner GV, Gordon DB, Hilton MJ, Forni LG, McKinnon W, Ismail FM, Keenan M, et al. (1996) An inhibitor ofthe sodium pump obtained from human placenta. Lancet 348:303-305.
178. Hillyard SD, Lu E, and Gonick HC (1976) Further characterization of the natriuretic factor derived from kidney tissue of volume-expanded rats: effects on short-circuit current and sodium-potassium-adenosine triphosphatase activity. Circ Res 38:250 -255.
179. Ho CS, Butt A, Semra YK, and Swaminathan R (1997) Effect of carbidopa on the excretion of sodium, dopamine, and ouabain-like substance in the rat. Hypertension 30:1544-1548.
180. Hopate M, Graves S, Adair D, Lam G, Johnson D, Saade G, Lewis D, Porter K, Humphrey R, and Chauhan N (2008) In-vivo reversal of functional sodium pump inhibition with Digibind treatment, in Proceedings of the XVIth Congress of the International Society for the Study of Hypertension in Pregnancy; 2008 Sept 20-24; Washington DC. p 69, International Society for the Study of Hypertension in Pregnancy, Rotterdam, The Netherlands.
181. Howard R and Foerstl H (1990) Toad-lickers psychosis a warning. Br J Psychiatry 157:779-780.
182. Huang BS, Amin MS, and Leenen FH (2006) The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol 21:295-304.
183. Huang BS, Kudlac M, Kumarathasan R, and Leenen FH (1999) Digoxin prevents ouabain and high salt intake-induced hypertension in rats with sinoaortic denervation. Hypertension 34:733-738.
184. Huang BS and Leenen FH (1996a) Brain "ouabain" and angiotensin II in saltsensitive hypertension in spontaneously hypertensive rats. Hypertension 28:1005 1012.
185. Huang BS and Leenen FH (1996b) Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANGII. Am J Physiol 270:H275-H280.
186. Huang BS and Leenen FH (1998) Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake. Hypertension 32:1028-1033.
187. +] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol Heart Circ Physiol 287:H1160-H1166.
188. +-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 267:5040 -5043.
189. Itabashi A, Chan L, Shapiro JI, Cheung C, and Schrier RW (1987) Comparison of the natriuretic response to atriopeptin III and loop diuretic in the isolated perfused rat kidney. Clin Sci (Lond) 73:143-150.
190. 2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 290:R536 -R545.
191. 2+ exchanger type-1 in vascular smooth muscle. Nat Med 10:1193-1199.
192. J0rgensen PL (1986) Structure, function and regulation of Na,K-ATPase in the kidney. Kidney Int 29:10 -20.
193. Jørgensen PL (1990) Structure and molecular mechanisms of the Na,K-pump, in Monovalent Cations in Biological Systems (Pasternak CA, ed) pp 117-154, CRC, Boca Raton, FL.
194. + pump α subunit isoforms in plasmalemma: physiological implications. Ann N Y Acad Sci 834:524-536.
195. + pump low and high ouabain affinity α subunit isoforms are differently distributed in cells. Proc Natl Acad Sci U S A 94:1800 -1805.
196. Käcolonhönen M, Doris PA, Makynen H, and Pörsti I (1995) Plasma digoxin immunore activity and arterial potassium relaxation after quinapril therapy in hypertensive rats. J Pharmacol Exp Ther 275:832-837.
197. Kaminski K and Rechberger T (1991) Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy induced hypertension. Am J Obstet Gynecol 165:733-736.
198. Kaplan MA, Bourgoignie JJ, Rosecan J, and Bricker NS (1974) The effects of the natriuretic factor from uremic urine on sodium transport, water and electrolyte content, and pyruvate oxidation by the isolated toad bladder. J Clin Invest 53:1568-1577.
199. Kashkin VA, Zvartau EE, Fedorova OV, Bagrov YY, Lakatta EG, and Bagrov AY (2008) Endogenous bufadienolide mediates pressor response to ethanol withdrawal in rats. Eur Neuropsychopharmacol 18:74-77.
200. + ions. J Biochem 126:278-286.
201. Ke YS, Wang DG, Wang HG, and Yang SY (2004) Endoxin antagonist lessens myocardial ischemia reperfusion injury. Cardiovasc Drugs Ther 18:289 -293.
202. Kelly RA (1986) Excretion of artifactual endogenous digitalis-like factors. Am J Physiol 251:H205-H209.
203. Kelly RA and Smith TW (1992) Is ouabain the endogenous digitalis? Circulation 86:694-697.
204. Kennedy D, Omran E, Periyasamy SM, Nadoor J, Priyadarshi A, Willey JC, Malhotra D, Xie Z, and Shapiro JI (2003) Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J Am Soc Nephrol 14:90 -97.
205. Kennedy DJ, Elkareh J, Shidyak A, Shapiro AP, Smaili S, Mutgi K, Gupta S, Tian J, Morgan E, Khouri S, et al. (2007) Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am J Physiol Renal Physiol 294:F450 -F454.
206. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, et al. (2006a) Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47:488-495.
207. Kennedy DJ, Vetteth S, Xie M, Periyasamy SM, Xie Z, Han C, Basrur V, Mutgi K, Fedorov V, Malhotra D, and Shapiro JI (2006b) Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation. Am J Physiol Heart Circ Physiol 291:H3003-H3011.
208. Kieval RS, Butler VP Jr, Derguini F, Bruening RC, and Rosen MR (1988) Cellular electrophysiologic effects of vertebrate digitalis-like substances. J Am Coll Cardiol 11:637-643.
209. Klein M, Nejad NS, Lown B, Hagemeijer F, and Barr I (1971) Correlation of the electrical and mechanical changes in the dog heart during progressive digitalization. Circ Res 29:635-645.
210. Koga M, Ideishi M, Matsusaki M, Tashiro E, Kinoshita A, Ikeda M, Tanaka H, Shindo M, and Arakawa K (1992) Mild exercise decreases plasma endogenous digitalislike substance in hypertensive individuals. Hypertension 19:II231-II236.
211. Kojima I, Yoshihara S, and Ogata E (1982) Involvement of endogenous digitalis-like substance in genesis of deoxycorticosterone-salt hypertension. Life Sci 30:1775-1781.
212. +-ATPase to growth-related genes in cardiac myocytes: the roles of Ras and mitogen-activated protein kinases. J Biol Chem 273:15249 -15256.
213. Komiyama Y, Dong XH, Nishimura N, Masaki H, Yoshika M, Masuda M, and Takahashi H (2005) A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin Biochem 38:36 -45.
214. Komiyama Y, Kimura Y, Nishimura N, Hara K, Mori T, Okuda K, Munakata M, Masuda M, Murakami T, and Takahashi H (1997) Vasodepressor effects of exercise are accompanied by reduced circulating ouabainlike immunoreactivity and normalization of nitric oxide synthesis. Clin Exp Hypertens 19:363-372.
215. Komiyama Y, Nishimura N, Munakata M, Mori T, Okuda K, Nishino N, Hirose S, Kosaka C, Masuda M, and Takahashi H (2001) Identification of endogenous ouabain in culture supernatant of PC12 cells. J Hypertens 19:229 -236.
216. Komiyama Y, Nishimura N, Munakata M, Okuda K, Nishino N, Kosaka C, Masuda M, Mori T, Matsuda T, and Takahashi H (1999) Increases in plasma ouabainlike immunoreactivity during surgical extirpation of pheochromocytoma. Hypertens Res 22:135-139.
217. Komiyama Y, Nishimura N, Nishino N, Okuda K, Munakata M, Kosaka C, Masuda M, and Takahashi H (1998) Purification and characterization of ouabain-binding protein in human plasma. Clin Exp Hypertens 20:683-690.
218. Kotova O, Al-Khalili L, Talia S, Hooke C, Fedorova OV, Bagrov AY, and Chibalin AV (2006) Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism. J Biol Chem 281:20085-20094.
219. Kramer HJ and Gonick HC (1974) Effect of extracellular volume expansion on renal Na-K-ATPase and cell metabolism. Nephron 12:281-296.
220. Lam G, Johnson D, Robinson C, Saade G, Lewis D, Porter K, Humphrey R, Adair C, Buckalew V, and Danoff T (2008) Antepartum administration of a digoxin immune Fab (Digibind) improves renal function in patients with severe preeclampsia, in Proceedings of the XVIth Congress of the International Society for the Study of Hypertension in Pregnancy; 2008 Sept 20-24; Washington DC. p 60, International Society for the Study of Hypertension in Pregnancy, Rotterdam, The Netherlands.
221. Langer GA (1972) Effects of digitalis on myocardial ionic exchange. Circulation 46:180 -187.
222. Laredo J, Hamilton BP, and Hamlyn JM (1994) Ouabain is secreted by bovine adrenocortical cells. Endocrinology 135:794-797.
223. Laredo J, Hamilton BP, and Hamlyn JM (1995) Secretion of endogenous ouabain from bovine adrenal cells: role of zona glomerulosa and zona fasciculata. Biochem Biophys Res Commun 212:487-493.
224. Laredo J, Shah JR, Lu ZR, Hamilton BP, and Hamlyn JM (1997) Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 29:401-407.
225. Larre I, Ponce A, Fiorentino R, Shoshani L, Contreras RG, and Cereijido M (2006) Contacts and cooperation between cells depend on the hormone ouabain. Proc Natl Acad Sci U S A 103:10911-10916.
226. Lee CY and Burnett JC Jr (2007) Natriuretic peptides and therapeutic applications. Heart Fail Rev 12:131-142.
227. Leenen FH, Yuan B, and Huang BS (1999) Brain "ouabain" and angiotensin II contribute to cardiac dysfunction after myocardial infarction. Am J Physiol 277:H1786 -H1792.
228. Lesney MS (2002) Flowers for the heart. Mod Drug Discov 5:46 -48.
229. Levenson R (1994) Isoforms of the Na,K-ATPase: family members in search of function. Rev Physiol Biochem Pharmacol 123:1-45.
230. Levinson PD, McGarvey ST, Carlisle CC, Eveloff SE, Herbert PN, and Millman RP (1993) Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 103:1336 -1342.
231. Li R, el-Mallakh RS, Harrison L, Changaris DG, and Levy RS (1997) Lithium prevents ouabain-induced behavioral changes toward an animal model for manic depression. Mol Chem Neuropathol 31:65-72.
232. Liang M, Tian J, Liu L, Pierre S, Liu J, Shapiro J, and Xie ZJ (2007) Identification of a pool of non-pumping Na/K-ATPase. J Biol Chem 282:10585-10593.
233. Lichtstein D, Gati I, Babila T, Haver E, and Katz U (1991) Effect of salt acclimation on digitalis-like compounds in the toad. Biochim Biophys Acta 1073:65-68.
234. Lichtstein D, Gati I, and Ovadia H (1993) Digitalis-like compounds in the toad Bufoviridis: interactions with plasma proteins. J Cardiovasc Pharmacol 22 (Suppl 2):S102-S105.
235. Lichtstein D, Gati I, Samuelov S, Berson D, Rozenman Y, Landau L, and Deutsch J (1993) Identification of digitalis-like compounds in human cataractous lenses. Eur J Biochem 216:261-268.
236. Lichtstein D, Steinitz M, Gati I, Samuelov S, Deutsch J, and Orly J (1998) Biosynthesis of digitalis-compound in rat adrenal cells: hydroxycholesterol as a precursor. Life Sci 62:2109 -2126.
237. Lindenmayer GE (1976) Mechanism of action of digitalis glycosides at the subcellular level. Pharmacol Ther [B] 2:843-861.
238. Ling G (2007) History of the membrane (pump) theory of the living cell from its beginning in mid-19th century to its disproof 45 years ago though still taught worldwide today as established truth. Physiol Chem Phys Med NMR 39:1-67.
239. Lingrel JB (1992) Na,K-ATPase: isoform structure, function, and expression. J Bioenerg Biomembr 24:263-270.
240. Liu J, Kesiry R, Periyasamy SM, Malhotra D, Xie Z, and Shapiro JI (2004) Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int 66:227-241.
241. Liu J, Liang M, Liu L, Malhotra D, Xie Z, and Shapiro JI (2005) Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int 67:1844 -1854.
242. Liu J, Periyasamy SM, Gunning W, Fedorova OV, Bagrov AY, Malhotra D, Xie Z, and Shapiro JI (2002) Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney Int 62:2118-2125.
243. Liu J and Shapiro JI (2007) Regulation of sodium pump endocytosis by cardiotonic steroids: molecular mechanisms and physiological implications. Pathophysiology 14:171-181.
244. 2+ concentrations. J Biol Chem 275:27838-27844.
245. +-ATPase. Am J Physiol Cell Physiol 284:C1550-C1560.
246. Liu ZQ, Ma AQ, Zhang L, and Yang DY (1990) Intra-cellular electrolyte changes and levels of endogenous digoxin-like substance within the plasma in patients with congestive heart failure. Int J Cardiol 27:47-53.
247. London GM and Parfrey PS (1997) Cardiac disease in chronic uremia: Pathogenesis. Adv Ren Replace Ther 4:194-211.
248. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, and Bagrov AY (1999) Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 17:1179 -1187.
249. Loreaux EL, Kaul B, Lorenz JN, and Lingrel JB (2008) Ouabain-sensitive a1 Na,K ATPase enhances natriuretic response to saline load. J Am Soc Nephrol 19:1947-1954.
250. +-ATPase subunit. Am J Physiol Heart Circ Physiol 295:H273-H280.
251. Ludens JH, Clark MA, DuCharme DW, Harris DW, Lutzke BS, Mandel F, Mathews WR, Sutter DM, and Hamlyn JM (1991) Purification ofan endogenous digitalislike factor from human plasma for structural analysis. Hypertension 17:923-929.
252. Ludens JH, Clark MA, Kolbasa KP and Hamlyn JM (1993) Digitalis-like factor and ouabain-like compound in plasma of volume-expanded dogs. J Cardiovasc Pharmacol 22 (Suppl 2):S38-S41.
253. Lyttle T, Goldstein D, and Gartz J (1996) Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic. J Psychoactive Drugs 28:267-290.
254. Lytton J, Lin JC, and Guidotti G (1985) Identification of two molecular forms of (Na,K)-ATPase in rat adipocytes. Relation to insulin stimulation of the enzyme. J Biol Chem 260:1177-1184.
255. Maixent JM and Lelievre LG (1987) Differential inactivation of inotropic and toxic digitalis receptors in ischemic dog heart: molecular basis of the deleterious effects of digitalis. J Biol Chem 262:12458-12462.
256. Manunta P, Ferrandi M, Bianchi G, and Hamlyn JM (2009) Endogenous ouabain in cardiovascular function and disease. J Hypertens 27:9 -18.
257. Manunta P, Hamilton BP, and Hamlyn JM (2006) Salt intake and depletion increase circulating levels ofendogenous ouabain in normal men. Am J Physiol Regul Integr Comp Physiol 290:R553-R559.
258. Manunta P, Maillard M, Tantardini C, Simonini M, Lanzani C, Citterio L, Stella P, Casamassima N, Burnier M, Hamlyn JM, et al. (2008) Relationships among endogenous ouabain, α-adducin polymorphisms and renal sodium handling in primary hypertension. J Hypertens 26:914-920.
259. Manunta P, Messaggio E, Ballabeni C, Sciarrone MT, Lanzani C, Ferrandi M, Hamlyn JM, Cusi D, Galletti F, and Bianchi G (2001) Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension 38:198-203.
260. Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M, Hamlyn JM, and Bianchi G (1999) Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 34:450 -456.
261. Markou A, Kosten TR, and Koob GF (1998) Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18:135-174.
262. Marks MJ and Seeds NW (1978) A heterogeneous ouabain-ATPase interaction in mouse brain. Life Sci 23:2735-2744.
263. Martinka E, Galajada P, Ochodnicky M, Lichardus B, Straka S, and Mokan M (1997) Endogenous digoxinlike immunoreactivity and diabetes mellitus: facts and hypotheses. Med Hypotheses 49:271-275.
264. Masilamani S, Castro L, and Baylis C (1994) Pregnant rats are refractory to the natriuretic actions of ANP. Am J Physiol 267:R1611-R1616
265. Masuda Y, Kawazoe N, Nakajo S, Yoshida T, Kuroiwa Y, and Nakaya K (1995) Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res 19:549-556. McDonough AA, Wang J, and Farley RA (1995) Significance of sodium pump isoforms in digitalis therapy. J Mol Cell Cardiol 27:1001-1009.
266. McGrail KM, Phillips JM, and Sweadner KJ (1991) Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na,K-ATPase. J Neurosci 11:381-391.
267. Meneton P, Jeunemaitre X, de Wardener HE, and MacGregor GA (2005) Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85:679 -715.
268. Menezes JC, Troster EJ, and Dichtchekenian V (2003) Digoxin antibody decreases natriuresis and diuresis in cerebral hemorrhage. Intensive Care Med 29:2291-2296.
269. Meyer K and Linde H (1971) Collection of toad venoms and chemistry of the toad venom steroids, in Venomous Animals and Their Venoms (Bucherl W and Buckley E eds), Academic Press, London.
270. Middleton RJ, Parfrey PS, and Foley RN (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12:1079-1084.
271. Mijatovic T, De Neve N, Gailly P, Mathieu V, Haibe-Kains B, Bontempi G, Lapeira J, Decaestecker C, Facchini V, and Kiss R (2008) Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Mol Cancer Ther 7:1285-1296.
272. Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, and Kiss R (2007) Cardiotonic steroids on the road to anti-cancer therapy. Biochim Biophys Acta 1776:32-57.
273. +-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep 20:51-91.
274. Mohmand B, Malhotra DK, and Shapiro JI (2005) Uremic cardiomyopathy: role of circulating digitalis like substances. Front Biosci 10:2036-2044.
275. Morise T, Okamoto S, Takasaki H, Ikeda M, Takeda R, Kiuti F, and Tuda Y (1988) Biological activity of partially purified digitalis-like substance and Na-K-ATPase inhibitor in rats. Jpn Circ J 52:1309-1316.
276. +-ATPase alpha(1)beta(1), alpha(2)beta(1), and alpha(3)beta(1) when expressed separately in yeast cells. Am J Physiol Cell Physiol 281:C1355-C1364.
277. Murrll JR, Randall JD, RosoffJ, Zhao JL, Jensen RV, Gullans SR, and Haupert GT Jr (2005) Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal. Circulation 112:1301-1308.
278. Nakamoto M, Shapiro JI, Shanley PF, Chan L, and Schrier RW (1987) In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest 80:698-705.
279. Naruse K, Naruse M, Tanabe A, Yoshimoto T, Watanabe Y, Kurimoto F, Horiba N, Tamura M, Inagami T and Demura H (1994) Does plasma immunoreactive ouabain originate from the adrenal gland? Hypertension 23(1 Suppl):I102-I105.
280. Naylor GJ, Dick DA, Dick EG, Le Poidevin D, and Whyte SF (1973) Erythrocyte membrane cation carrier in depressive illness. Psychol Med 3:502-508.
281. Neuss M, Crow MT, Chesley A, and Lakatta EG (2001) Apoptosis in cardiac disease what is it how does it occur. Cardiovasc Drugs Ther 15:507-523.
282. Newman RA, Yang P, Pawlus AD, and Block KI (2008) Cardiac glycosides as novel cancer therapeutic agents. Mol Interv 8:36 -49.
283. Nesher M, Shpolansky U, Rosen H, and Lichtstein D (2007) The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci 80:2093-2107.
284. Nguyen AN, Wallace DP, and Blanco G (2007) Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation. J Am Soc Nephrol 18:46-57.
285. Nhamburo PT, Salafsky BP, Hoffman PL, and Tabakoff B (1986) Effects of shortchain alcohols and norepinephrine on brain Na,K-ATPase activity. Biochem Pharmacol 35:1987-1992.
286. Nhamburo PT, Salafsky BP, Tabakoff B, and Hoffman PL (1987) Effects ofethanol on ouabain inhibition of mouse brain Na,K-ATPase activity. Biochem Pharmacol 36:2027-2033.
287. Nicholls MG, Lewis LK, Yandle TG, Lord G, McKinnon W, and Hilton PJ (2009) Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease: fact or fantasy? J Hypertens 27:3-8.
288. Numazawa S, Honma Y, Yamamoto T, Yoshida T, and Kuroiwa Y (1995) A cardiotonic steroid bufalin-like factor in human plasma induces leukemia cell differentiation. Leuk Res 19:945-953.
289. Numazawa S, Shinoki MA, Ito H, Yoshida T, and Kuroiwa Y (1994) Involvement of Na,K-ATPase inhibition in K562 cell differentiation induced by bufalin. J Cell Physiol 160:113-120.
290. Oda M, Kurosawa M, Numazawa S, Tanaka S, Akizawa T, Ito K, Maeda M, and Yoshida T (2001) Determination of bufalin-like immunoreactivity in serum of humans and rats by time-resolved fluoroimmunoassay for using a monoclonal antibody. Life Sci 68:1107-1117.
291. Orlov SN and Hamet P (2004) Apoptosis vs. oncosis: role of cell volume and intracellular monovalent cations. Adv Exp Med Biol 559:219-233.
292. +i-sensitive signalling. Acta Physiol (Oxf) 187:231-240.
293. Orlov SN and Mongin AA (2007) Salt-sensing mechanisms in blood pressure regulation and hypertension. Am J Physiol Heart Circ Physiol 293:H2039 -H2053.
294. +]i. Pflugers Arch 448:335-345. Overbeck HW, Pamnani MB, Akera T, Brody TM, and Haddy FJ (1976) Depressed function of a ouabain-sensitive sodium-potassium pump in blood vessels from renal hypertensive dogs. Circ Res 38(6 Suppl 2):48-52.
295. Oweis S, Wu L, Kiela PR, Zhao H, Malhotra D, Ghishan FK, Xie Z, Shapiro JI, and Liu J (2006) Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells. Am J Physiol Renal Physiol 290:F997-F1008.
296. Paci A, Marrone O, Lenzi S, Prontera C, Nicolini G, Ciabatti G, Ghione S, and Bonsignore G (2000) Endogenous digitalis-like factors in obstructive sleep apnea. Hypertens Res 23 (Suppl):S87-S91.
297. Padilha AS, Pecanha FM, Vassallo DV, Alonso MJ, and Salaices M (2008) Ouabain treatment changes the role of endothelial factors in rat resistance arteries. Eur J Pharmacol 600:110-116.
298. Pamnani MB, Whitehorn WV, Clough DL, and Haddy FJ(1990) Effects ofcanrenone on blood pressure in rats with reduced renal mass. Am J Hypertens 3:188-195.
299. Parhami-Seren B, Haberly R, Margolies MN, and Haupert GT Jr (2002) Ouabain binding protein(s) from human plasma. Hypertension 40:220 -228.
300. Periyasamy SM, Chen J, Cooney D, Carter P, Omran E, Tian J, Priyadarshi S, Bagrov A, Fedorova O, Malhotra D, et al. (2001) Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function. Kidney Int 60:2367-2376.
301. Periyasamy SM, Liu J, Tanta F, Kabak B, Wakefield B, Malhotra D, Kennedy DJ, Nadoor A, Fedorova OV, Gunning W, et al. (2005) Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int67:1868-1877.
302. Perrin A, Brasmes B, Chambaz EM, and Defaye G (1997) Bovine adrenocortical cells in culture synthesize an ouabain-like compound. Mol Cell Endocrinol 126:7-15.
303. +)-activated adenosine triphosphatase from Artemia salina nauplii. J Biol Chem 253:4762-4770.
304. Pierdomenico SD, Bucci A, Manunta P, Rivera R, Ferrandi M, Hamlyn JM, Lapenna D, Cuccurullo F, and Mezzetti A (2001) Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am J Hypertens 14:44-50.
305. Pierre SV, Sottejeau Y, Gourbeau JM, Sanchez G, Shidyak A, and Blanco G (2008) Isoform-specificity of Na,K-ATPase-mediated ouabain signaling. Am J Physiol Renal Physiol 294:F859 -F866.
306. Pierre SV and Xie Z (2006) The Na,K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys 46:303-316.
307. Pleasants RA, Gadsden RH Sr, McCormack JP, Piveral K, and Sawyer WT (1986) Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function. Clin Pharm 5:810 -816.
308. 14Cin Scilla maritima and Bufo paracnemis. Experientia 26:11.
309. 14C. Experientia 27:506.
310. Post RL, Hegyvary C, and Kume S (1972) Activation by adenosine triphosphate in the phosphorylation kinetics of sodium and potassium ion transport adenosine triphosphatase. J Biol Chem 247:6530 -6540.
311. Poston L, Morris JF, Wolfe CD, and Hilton PJ (1989) Serum digoxin-like substances in pregnancy-induced hypertension. Clin Sci (Lond) 77:189 -194.
312. Priyadarshi S, Valentine B, Han C, Fedorova OV, Bagrov AY, Liu J, Periyasamy SM, Kennedy D, Malhotra D, Xie Z, et al. (2003) Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Kidney Int 63:1785-1790.
313. Qazzaz HM, Cao Z, Bolanowski DD, Clark BJ, and Valdes R Jr (2004) De novo biosynthesis and radiolabeling of mammalian digitalis-like factors. Clin Chem 50:612-620.
314. Qazzaz HM, Goudy SL, and Valdes R Jr (1996) Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue. J Biol Chem 271:8731-8737.
315. Rein H (1949) Uber ein Regulaionssystem "Mils-Leber" fur den oxydativen stiffwechsel der Korperwebe und besonders des Herzens. Naturwissenschaften 8:233-239.
316. Repke KR (1972) Biochemical principles of the development of new cardiac drugs of the digitalis type. Pharmazie 27:693-701.
317. Ritz E (1994) Presentation of the 1993 Jean Hamburger Award to Hugh E. de Wardener by Eberhard Ritz. Kidney Int Suppl 44:S114-S115.
318. Ritz E (1996) The history of salt aspects of interest to the nephrologist. Nephrol Dial Transplant 11:969 -975.
319. Ritz E, Dikow R, Morath C, and Schwenger V (2006) Salt a potential 'uremic toxin'? Blood Purif 24:63-66.
320. Rodrigues-Mascarenhas S, dos Santos NF, and Rumjanek VM (2006) Synergistic effect between ouabain and glucocorticoids for the induction of thymic atrophy. Biosci Rep 26:159 -169.
321. Rossoni LV, Salaices M, Miguel M, Briones AM, Barker LA, Vassallo DV, and Alonso MJ (2002) Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors. Am J Physiol Heart Circ Physiol 283:H2110 -H2118.
322. Rossoni LV, Xavier FE, Moreira CM, Falcochio D, Amanso AM, Tanoue CU, Carvalho CR, and Vassallo DV (2006) Ouabain-induced hypertension enhances left ventricular contractility in rats. Life Sci 79:1537-1545.
323. Rubattu S and Volpe M (2001) The atrial natriuretic peptide: a changing view. J Hypertens 19:1923-1931.
324. Ruktanonchai DJ, el-Mallakh RS, Li R, and Levy RS (1998) Persistent hyperreactivity following a single intracerebroventricular dose of ouabain. Physiol Behav 63:403-406.
325. +-ATPase subunit isoform pattern modification by mitogenic insulin concentration in 3T3-L1 preadipocytes. Am J Physiol 264:C311-C316.
326. Rybakowski JK and Lehmann W (1994) Decreased activity of erythrocyte membrane ATPases in depression and schizophrenia. Neuropsychobiology 30:11-14.
327. Scavone C, Scanlon C, McKee M, and Nathanson JA (1995) Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J Pharmacol Exp Ther 272:1036 -1043.
328. Schmidt RW, Bourgoignie JJ, and Bricker NS (1974) On the adaptation in sodium excretion in chronic uremia: the effects of "proportional reduction" of sodium intake. J Clin Invest 53:1736 -1741.
329. Schneider R, Wray V, Nimtz M, Lehmann WD, Kirch U, Antolovic R, and Schoner W (1998) Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J Biol Chem 273:784-792.
330. Schoner W (1992) Endogenous digitalis-like factors. Clin Exp Hypertens A 14:767-814.
331. Schoner W and Scheiner-Bobis G (2007) Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293:C509 -C536.
332. Schreiber V, Kolbel F, Stepan J, Gregorova I, and Pribyl T (1981a) Digoxin-like immunoreactivity in the serum of rats with cardiac overload. J Mol Cell Cardiol 13:107-110.
333. Schreiber V, Stěcolonṕn J, Gregorova I, and Krejcícolonková J (1981b) Crossed digoxin immunoreactivity in chromatographic fractions of rat adrenal extract. Biochem Pharmacol 30:805-806.
334. Schrier RW (1974) Effects of drenergic nervous system nd c techol mines on systemic nd ren l hemodyn mics, sodium nd wa ter excretion nd renin secretion. Kidney Int 6:291-306.
335. Schrier RW nd Abr h m WT (1999) Hormones and hemodyn mics in heart failure.N Engl J Med 341:577-585.
336. Schrier RW, McDon ld KM, M rsh ll RA, nd L uler DP (1968) Absence of n triuretic response to acute hypotonic intr v scul r volume expa nsion in dogs. Clin Sci 34:57-72.
337. Schrier RW, Verroust PJ, Jones JJ, F abia n M, Lee J, nd De Wa rdener HE (1968b) Effect of isotonic s line infusion and cute h emorrh ge on plsm oxytocin and v sopressin concentr tions in dogs. Clin Sci 35:433-443.
338. 2+ exchanger protein levels in human heart failure. Circulation 99:2105-2512.
339. Selye H, Mécs I, and Tamura T (1969) Effect of spironolactone and norbolethone on the toxicity of digitalis compounds in the rat. Br J Pharmacol 37:485-488.
340. Semplicini A, Buzzaccarini F, Ceolotto G, Marzola M, Mozzato MG, Giusto M, Campagnolo M, Simonella C, and Pessina AC (1993) Effects of canrenoate on red cell sodium transport and calf flow in essential hypertension. Am J Hypertens 6:295-301.
341. Semplicini A, Serena L, Valle R, Ceolotto G, Felice M, Fontebasso A, and Pessina AC (1995) Ouabain-inhibiting activity of aldosterone antagonists. Steroids 60:110 -113.
342. Shah JR, Laredo J, Hamilton BP, and Hamlyn JM (1998) Different signaling pathways mediate stimulated secretions of endogenous ouabain and aldosterone from bovine adrenocortical cells. Hypertension 31:463-468.
343. Shah JR, Laredo J, Hamilton BP, and Hamlyn JM (1999) Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells. Hypertension 33:373-377.
344. Shamraj OI, Grupp IL, Grupp G, Melvin D, Gradoux N, Kremers W, Lingrel JB, and De Pover A (1993) Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovasc Res 27:2229 -2237.
345. +-ATPase a-subunit gene is expressed in testis. Proc Natl Acad Sci U S A 91:12952-12956.
346. Sheiner LB, Rosenberg B, Marathe VV, and Peck C (1974) Differences in serum digoxin concentrations between outpatients and inpatients: an effect of compliance? Clin Pharmacol Ther 15:239 -246.
347. Shrivastav P, Gill DS, D'Souza V, O'Brien PM, and Dandona P (1988) Secretion of atrial natriuretic peptide and digoxin-like immunoreactive substance during pregnancy. Clin Chem 34:977-980.
348. +-ATPase subunit from rat brain. Biochemistry 25:8125-8132.
349. +)ATPase deduced from a complementary DNA. Nature 316:61-695.
350. Sibai B, Dekker G, and Kupferminc M (2005) Pre-eclampsia. Lancet 365:785-799.
351. Sich B, Kirch U, Tepel M, Zidek W, and Schoner W (1996) Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound. Hypertension 27:1073-1078.
352. Siperstein MD, Murray AW, and Titus E (1957) Biosynthesis of cardiotonic sterols from cholesterol in the toad, Bufo marinus. Arch Biochem Biophys 67:154-160.
353. Skou JC (1957) The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim Biophys Acta 23:394 -401.
354. Skou JC and Esmann M (1992) The Na,K-ATPase. J Bioenerg Biomembr 24:249 -261.
355. Smith TW and Haber E (1973) Digitalis. I. N Engl J Med 289:945-952.
356. Sophocleous A, Elmatzoglou I, and Souvatzoglou A (2003) Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent. J Endocrinol Invest 26:668-674.
357. Soderholm M, Hebert H, Skriver E, and Maunsbach AB (1988) Assembly of two dimensional membrane crystal of Na,K-ATPase. J Ultrastruct Mol Struct Res 99:234 -243.
358. Staessen JA, Kuznetsova T, Acceto R, Bacchieri A, Brand E, Burnier M, Celis H, Citterio L, de Leeuw PW, Filipovsky J, et al. (2005) OASIS-HT: design of a pharmacogenomic dose-finding study. Pharmacogenomics 6:755-775.
359. Stamler J, Rose G, Elliott P, Dyer A, Marmot M, Kesteloot H, and Stamler R (1991) Findings of the International Cooperative INTERSALT Study. Hypertension 17 (Suppl 1):I9 -I15.
360. Stenkvist B, Pengtsson E, Dahlquist B, Eriksson O, Jarkrans T, and Nordin B (1982) Cardiac glycosides and breast cancer, revisited. N Engl J Med 306:484.
361. Stoklosa T, Poplawski T, Koptyra M, Nieborowska-Skorska M, Basak G, Slupianek A, Rayevskaya M, Seferynska I, Herrera L, Blasiak J, et al. (2008) BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations. Cancer Res 68:2576 -2580.
362. Straub RH, Hall C, Kramer BK, Elbracht R, Palitzsch KD, Lang B, and Scholmerich J (1996) Atrial natriuretic factor and digoxin-like immunoreactive factor in diabetic patients: their interrelation and the influence of the autonomic nervous system. J Clin Endocrinol Metab 81:3385-3389.
363. +-ATPase genes: no less than five genes and/or pseudogenes related to the subunit. FEBS Lett 217:275-278.
364. +)-stimulated ATPase in brain: separation, and difference in affinity for strophanthidin. J Biol Chem 254:6060-6067.
365. +-ATPase. Biochim Biophys Acta 988:185-220.
366. Sweadner KJ and Rael E (2000) The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 68:41-56.
367. Szent-Gyorgyi A (1953) Chemical Physiology of Contraction in Body and Heart Muscle. Academic Press, New York.
368. Takahashi H, Iyoda I, Takeda K, Sasaki S, Okajima H, Yamasaki H, Yoshimura M, and Ijichi H (1984) Centrally-induced vasopressor responses to sodium-potassium adenosine triphosphatase inhibitor, ouabain, may be mediated via angiotensin II in the anteroventral third ventricle in the brain. Jpn Circ J 48:1243-1250.
369. Takahashi H, Matsusawa M, Ikegaki I, Suga K, Nishimura M, Yoshimura M, Yamada H, and Sano Y (1988) Digitalis-like substance is produced in the hypothalamus but not in the adrenal gland in rats. J Hypertens Suppl 6:S345-S457.
370. Tao QF, Soszynski PA, Hollenberg NK, and Graves SW (1996) Specificity of theolume-sensitive sodium pump inhibitor isolated from human peritoneal dialysate in chronic renal failure. Kidney Int 49:420 -429.
371. Therien AG and Blostein R (2000) Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol 279:C541-C566.
372. +-ATPase forms a functional signaling complex. Mol Biol Cell 17:317-326.
373. ATP channels. Mol Cell Biochem 242:181-187.
374. Tian J and Xie ZJ (2008) The Na-K-ATPase and calcium-signaling microdomains. Physiology (Bethesda) 23:205-211.
375. Tymiak AA, Norman JA, Bolgar M, DiDonato GC, Lee H, Parker WL, Lo LC, Berova N, Nakanishi K, and Haber E (1993) Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A 90:8189-8193.
376. Uddin MN, Horvat D, Glaser SS, Danchuk S, Mitchell BM, Sullivan DE, Morris CA, and Puschett JB (2008a) Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 29:266-273.
377. Uddin MN, Horvat D, Glaser SS, Mitchell BM, and Puschett JB (2008b) Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function. JBiol Chem 283:17946-17953.
378. Urayama O, Shutt H, and Sweadner KJ (1989) Identification of three isozymep roteins of the catalytic subunit of the Na,K-ATPase in rat brain. J Biol Chem 264:8271-8280.
379. +-ATPase to negatively charged amino acid residues mimic the functional effect of PKC-mediated phosphorylation. FEBS Lett 455:8-12.
380. + pumps for transport activity and ouabain binding. Biochim Biophys Acta 1368:137-149.
381. Vesely DL, Bayliss JM, and Sallman AL (1987) Human prepro atrial natriuretic factors 26 -55, 56 -92, and 104-123 increase renal guanylate cyclase activity. Biochem Biophys Res Commun 143:186-193.
382. Vu H, Ianosi-Irimie M, DanchukS, Rabon E, Nogawa T, Kamano Y, PettitGR, Wiese T, and Puschett JB (2006) Resibufogenin corrects hypertension in a rat model of human preeclampsia. Exp Biol Med (Maywood) 231:215-220.
383. Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY, Fedorova OV, Pridjian G, and Puschett JB (2005) The involvement of marinobufagenin in a rat model of human peeclampsia. Am J Nephrol 25:520 -528.
384. Waldorff S and Buch J (1979) Canrenoate a spironolactone metabolite: acute cardiac effects in digitalized patients. Eur J Cardiol 10:143-149.
385. +-ATPase. J Biol Chem 279:17250-17259.
386. Wang H and Leenen FH (2003) Brain sodium channels and central sodium-induced increases in brain ouabain-like compound and blood pressure. J Hypertens 21:1519-1524.
387. Wang JG, Staessen JA, Messaggio E, Nawrot T, Fagard R, Hamlyn JM, Bianchi G, and Manunta P (2003) Salt, endogenous ouabain and blood pressure interactions in the general population. J Hypertens 21:1475-1481.
388. Wasserstrom JA and Aistrup GL (2005) Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 289:H1781-H1793.
389. Watabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, and Nakaya K (1996) The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. JBiol Chem 271:14067-14072.
390. Weidemann H (2005) Na/K-ATPase, endogenous digitalis like compounds and cancer development a hypothesis. Front Biosci 10:2165-2176.
391. Weidemann H, Salomon N, Avnit-Sagi T, Weidenfeld J, Rosen H, and Lichtstein D (2004) Diverse effects of stress and additional adrenocorticotropic hormone on digitalis-like compounds in normal and nude mice. J Neuroendocrinol 16:458-463.
392. Weinberger MH (2006) Pathogenesis of salt sensitivity of blood pressure. Curr Hypertens Rep8:166-170.
393. Winnicka K, Bielawski K, Bielawska A, and Miltyk W (2007) Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells. Arch Pharm Res 30:1216-1224.
394. +-ATPase as a signal transducer. Eur J Biochem 269:2434-2439.
395. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 274:19323-19328.
396. Yamada K, Goto A, Nagoshi H, Hui C, and Omata M (1994) Role of brain ouabainlike compound in central nervous system-mediated natriuresis in rats. Hypertension 23:1027-1031.
397. Yeh BK and Lucchesi BR (1974) Letter: Potassium canrenoate and digitalis intoxication. Circ Res 35:963-967.
398. Yoshika M, Komiyama Y, Konishi M, Akizawa T, Kobayashi T, Date M, Kobatake S, Masuda M, Masaki H, and Takahashi H (2007) Novel digitalis-like factor, marinobufotoxin, isolated from cultured Y-1 cells, and its hypertensive effect in rats. Hypertension 49:209 -214.
399. +-ATPase. Proc Natl Acad Sci USA89:99-103.
400. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, Bianchi G, Ferrari P, Hamlyn JM, Iwamoto T, et al. (2005) Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. J Physiol 569:243-256.
401. Zhang LS, Nakaya K, Yoshida T, and Kuroiwa Y (1991) Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 178:686-693.
402. Zouzoulas A, Therien AG, Scanzano R, Deber CM, and Blostein R (2003) Modulation of Na,K-ATPase by the y subunit: studies with transfected cells and transmembrane mimetic peptides. J Biol Chem 278:40437-40441.
403. Zvartau NE, Conrady AO, Sviryaev YV, Rotari OP, Merkulova NK, Kalinkin AL, Shlyakhto EV, and Bagrov AY (2006) Marinobufagenin in hypertensive patients with obstructive sleep apnea. Cell Mol Biol (Noisy-le-grand) 52:24-27.